| MAPK1 |
MAPK1, ERK2, PRKM1, PRKM2: Mitogen-activated protein kinase 1 |
HNRPK |
HNRPK, HNRNPK: Heterogeneous nuclear ribonucleoprotein K |
3.34 |
Evidence |
|
| ARNT |
ARNT: Aryl hydrocarbon receptor nuclear translocator |
PRKCE |
PRKCE, PKCE: Protein kinase C epsilon type |
3.34 |
Evidence |
|
| MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
SLC9A3R2 |
SLC9A3R2: SLC9A3R2 protein (Fragment) |
3.34 |
Evidence |
|
| MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
AXIN1 |
|
3.34 |
Evidence |
|
| MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
JDP2 |
jdp2, JDP2: Jun dimerization protein 2 |
3.34 |
Evidence |
|
| MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
AR |
AR, DHTR, NR3C4: Androgen receptor |
3.34 |
Evidence |
|
| MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
C9orf88 |
IPI00647286 |
3.34 |
Evidence |
|
| MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
LOC642558 |
FUSIP1, FUSIP2, TASR: FUS-interacting serine-arginine-rich protein 1 |
3.34 |
Evidence |
|
| MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
DKFZp434K1815 |
DKFZp434K1815, hCG_1736780: Putative uncharacterized protein DKFZp434K1815 |
3.34 |
Evidence |
|
| MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
PPP1R12C |
PPP1R12C, MBS85: Protein phosphatase 1 regulatory subunit 12C |
3.34 |
Evidence |
|
| MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
C14orf151 |
C14orf151: Uncharacterized protein C14orf151 (Fragment) |
3.34 |
Evidence |
|
| MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
TCF20 |
TCF20, KIAA0292, SPBP: Transcription factor 20 |
3.34 |
Evidence |
|
| MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
PKP4 |
PKP4: Plakophilin-4 |
3.34 |
Evidence |
|
| MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
ZFP91 |
ZFP91, FKSG11: Zinc finger protein 91 homolog |
3.34 |
Evidence |
|
| MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
SF1 |
SF1, ZFM1, ZNF162: Splicing factor 1 |
3.34 |
Evidence |
|
| MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
YWHAG |
YWHAG: 14-3-3 protein gamma |
3.34 |
Evidence |
|
| MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
HNRPK |
HNRPK, HNRNPK: Heterogeneous nuclear ribonucleoprotein K |
3.34 |
Evidence |
|
| NFKBIA |
NFKBIA, IKBA, MAD3, NFKBI: NF-kappa-B inhibitor alpha |
CAMK4 |
CAMK4: Calcium/calmodulin-dependent protein kinase type IV |
3.34 |
Evidence |
|
| APC |
IPI00215877 |
AXIN1 |
|
3.34 |
Evidence |
|
| APC |
IPI00215877 |
SF1 |
SF1, ZFM1, ZNF162: Splicing factor 1 |
3.34 |
Evidence |
|
| APC |
IPI00215877 |
CDC42 |
IPI00016786 |
3.34 |
Evidence |
|
| APC |
IPI00215877 |
KRT6E |
KRT6C, KRT6E: Keratin, type II cytoskeletal 6C |
3.34 |
Evidence |
|
| ZP3 |
ZP3, ZP3A, ZP3B, ZPC: Zona pellucida sperm-binding protein 3 precursor |
DLG1 |
IPI00218729 |
3.34 |
Evidence |
|
| RXRA |
RXRA, NR2B1: Retinoic acid receptor RXR-alpha |
DUSP6 |
DUSP6, MKP3, PYST1: Dual specificity protein phosphatase 6 |
3.34 |
Evidence |
|
| RXRA |
RXRA, NR2B1: Retinoic acid receptor RXR-alpha |
DUSP16 |
DUSP16, KIAA1700, MKP7: Dual specificity protein phosphatase 16 |
3.34 |
Evidence |
|